Home
About
FAQ
History (8)
Percentage of positive biopsies associated with freedom from biochemical recurrence after low-dose-rate prostate brachytherapy alone for clinically localized prostate cancer.
Utility of frozen section analysis of resection margins during partial nephrectomy.
Body Burden
The management of urethral transitional cell carcinoma after radical cystectomy for invasive bladder cancer.
Docetaxel in the management of advanced pancreatic cancer.
See All 8 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Docetaxel in the management of advanced pancreatic cancer.
Lopes G, Rocha Lima CM. Docetaxel in the management of advanced pancreatic cancer. Semin Oncol. 2005 Apr; 32(2 Suppl 4):S10-23.
View in:
PubMed
subject areas
Antineoplastic Agents, Phytogenic
Antineoplastic Combined Chemotherapy Protocols
Camptothecin
Carboplatin
Chemotherapy, Adjuvant
Clinical Trials as Topic
Deoxycytidine
Fluorouracil
Humans
Neoadjuvant Therapy
Organoplatinum Compounds
Pancreatic Neoplasms
Taxoids
Thalidomide
authors with profiles
Caio S. Rocha Lima MS; MD